Relationship of biochemically persistent disease and thyroglobulin-doubling time to age at surgery in patients with papillary thyroid carcinoma
Authors:
Open Access
- 1 January 2013
- journal article
- Published by Japan Endocrine Society in Endocrine Journal
- Vol. 60 (4) , 415-421
Abstract
In patients with papillary thyroid carcinoma (PTC), detectable serum thyroglobulin (Tg) after total thyroidectomy implies biochemically persistent disease (BPD). We reported that the thyroglobulin-doubling time (Tg-DT) was a potent prognostic indicator in patients with BPD. To identify factors that are related to BPD and Tg-DT, we performed new analyses on the data gathered in our previous study. Using the data of 426 patients with PTC in whom the Tg-DT was computed after total thyroidectomy, multivariate logistic analyses for BPD and Tg-DT were performed. Postoperatively, 142 (33%) patients had BPD. The percentages of BPD patients were significantly higher among the young (<40 years) and elderly (≥60 years) patients compared to the middle-aged patients (41%, 41%, and 27%, respectively). Multivariate analysis showed that cN1b, tumor size ≥4 cm, and Ex2 were significantly associated with BPD. The percentage of patients with Tg-DT <2 years among the BPD patients increased with age: 6% in the young, 15% in the middle-aged, and 47% in the elderly patients. Multivariate analysis of the BPD patients revealed that Tg-DT was associated only with the age at surgery. The current analyses indicate that BPD is significantly correlated with the extent of disease status and that Tg-DT correlates only with patient age at surgery. Although our results clearly indicate that the biological behavior of PTC is age-related, the underlying reason for this remains to be established.Keywords
This publication has 15 references indexed in Scilit:
- Prognostic Factors for Recurrence of Papillary Thyroid Carcinoma in the Lymph Nodes, Lung, and Bone: Analysis of 5,768 Patients with Average 10‐year Follow‐upWorld Journal of Surgery, 2012
- Prognostic Impact of Serum Thyroglobulin Doubling-Time Under Thyrotropin Suppression in Patients with Papillary Thyroid Carcinoma Who Underwent Total ThyroidectomyThyroid®, 2011
- Prognostic Factors and Therapeutic Strategies for Differentiated Carcinomas of the ThyroidEndocrine Journal, 2009
- Papillary Thyroid Carcinoma: Factors Influencing Recurrence and SurvivalAnnals of Surgical Oncology, 2008
- Risk Factors Contributing to a Poor Prognosis of Papillary Thyroid Carcinoma: Validity of UICC/AJCC TNM Classification and Stage GroupingWorld Journal of Surgery, 2007
- Radioiodine Ablation of Thyroid Remnants after Preparation with Recombinant Human Thyrotropin in Differentiated Thyroid Carcinoma: Results of an International, Randomized, Controlled StudyThe Journal of Clinical Endocrinology & Metabolism, 2006
- A Single Recombinant Human Thyrotropin-Stimulated Serum Thyroglobulin Measurement Predicts Differentiated Thyroid Carcinoma Metastases Three to Five Years LaterThe Journal of Clinical Endocrinology & Metabolism, 2005
- Prognostic Factors Determining Long-Term Survival in Well-Differentiated Thyroid Cancer: An Analysis of Four Hundred Eighty-Four Patients Undergoing Therapy and Aftercare at the Same InstitutionThyroid®, 2003
- Current Controversies in the Management of Pediatric Patients with Well-Differentiated Nonmedullary Thyroid Cancer: A ReviewThyroid®, 2002
- Long-term impact of initial surgical and medical therapy on papillary and follicular thyroid cancerThe American Journal of Medicine, 1994